Taienkang announced that controlling shareholder Zheng Hanjie has released 33 million pledged shares, accounting for 31.12% of his holdings and 6.46% of the company's total share capital. As of the announcement date, Zheng Hanjie has a cumulative pledged share count of 21.62 million shares, representing 20.39% of his holdings and 4.23% of the company's total share capital. In the first quarter of 2026, Taienkang achieved revenue of 190 million yuan and net profit attributable to the parent company of 28.58 million yuan.
Guangdong Taienkang Pharmaceutical Co. LtdControlling shareholder releases 33 million pledged shares, reducing pledge ratio; no clear positive or negative signal for operations.